A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GSK updates prescribing information for the ovarian cancer drug Zejula, limiting use to second-line maintenance therapy only to patients with certain mutation types; change was made at the request of FDA following review of Phase 3 clinical results

GlaxoSmithKline's Blenrep to treat multiple myeloma fails to achieve primary endpoint in Phase 3 confirmatory trial

FDA accepts for priority review Gilead's sBLA for Trodelvy injectable for pre-treated HR+/HER2- metastatic breast cancer; sBLA based on Phase 3 data, which met its primary endpoint for progression-free survival

GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer

Sanofi partners with TrialSpark to pursue acquisition/in-licensing and development of clinical-stage Phase 2, Phase 3 drug candidates in areas of high unmet patient need; firms are jointly targeting six transactions over the next three years

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count